Eravacycline: a new treatment option for complicated intra-abdominal infections in the age of multidrug resistance.
Sign Up to like & getrecommendations! Published in 2019 at "Future microbiology"
DOI: 10.2217/fmb-2019-0135
Abstract: Aim: Recently approved for use in complicated intra-abdominal infection, eravacycline is a novel fluorocycline with broad spectrum of activity against resistant Gram-negative pathogens. This manuscript is a pooled analysis of two Phase III trials. Clinical… read more here.
Keywords: option; treatment; eravacycline versus; abdominal infections ... See more keywords